Opus Genetics IRD Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $59.96M+43.5% | $45.09M+48.7% | $30.82M-15.9% | $32.43M-21.7% | $41.79M-11.4% | ||
| $1.73M-43.8% | $2M-44.0% | $2.92M+57.0% | $3.4M+150% | $3.08M+60.1% | ||
| $66.6M+39.0% | $50.04M+36.7% | $35.91M-11.1% | $38.44M-14.3% | $47.93M-7.6% | ||
| $186K-22.2% | $199K-21.0% | $212K— | $226K— | $239K— | ||
| $66.79M+38.7% | $50.24M+36.3% | $36.12M-10.6% | $38.67M-13.8% | $48.17M-7.1% | ||
| $4.42M+82.0% | $3.29M+4.6% | $2.4M+184% | $1.47M+131% | $2.43M+17.7% | ||
| $9.34M-61.5% | $7.78M-31.1% | $29.09M+378% | $20.19M+381% | $24.25M+319% | ||
| $1.2M— | —— | —— | —— | —— | ||
| $77.35M+219% | $25.99M+130% | $30.16M+395% | $21.19M+405% | $24.25M+319% | ||
| 125M0.0% | 125M+4,166,567% | 125M0.0% | 125M+66.7% | 125M+66.7% | ||
| -$254.12M-72.6% | -$188.59M-35.7% | -$172.07M-65.7% | -$154.61M-60.5% | -$147.19M-66.2% | ||
| -$45.84M-1,004% | $15.35M+128% | $5.97M-82.6% | $17.47M-57.0% | $5.07M-89.0% | ||
| $66.79M+38.7% | $50.24M+36.3% | $36.12M-10.6% | $38.67M-13.8% | $48.17M-7.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Opus Genetics's total assets?
- Opus Genetics (IRD) holds $66.8M in total assets, up 38.7% year over year.
- How much debt does Opus Genetics have?
- Opus Genetics carries $1.2M in total debt against -$45.8M of shareholders' equity, a debt-to-equity ratio of 0.07.
- How much cash does Opus Genetics have?
- Opus Genetics holds $60.0M in cash and equivalents.
- Can Opus Genetics cover its short-term obligations?
- Its current ratio is 7.13 — current assets exceed current liabilities.
- Where does Opus Genetics's balance sheet data come from?
- Every line is extracted from Opus Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
